Sign Up Today and Learn More About Recursion Pharmaceuticals Stock
Invest in or calculate the value of your shares in Recursion Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Recursion Pharmaceuticals Stock
Automated drug discovery platform
Recursion Pharmaceuticals is an automated drug discovery platform. The company combines experimental biology, automation, and artificial intelligence in a parallel system that aims to efficiently identify treatments for any disease which can be modeled at the cellular level. The company uses computer vision to study images of how diseases affect healthy cells and claims to have put together the largest biological image set in the world, as it tracks almost half a million experiments a week. Recursion Pharmaceuticals has broadened its platform to probe data from automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. While the company tries to make its own drugs for rare discoveries, it has also sought partnerships with major pharmaceutical companies like Sanofi and Takeda, on other rare diseases, hoping to tackle oncology and inflammation.
About Recursion Pharmaceuticals Stock
Founded
2013
Headquarters
Salt Lake City, UT, US
Total Funding
206M
Industries
Software, Data and Analytics, Science and Engineering
Recursion Pharmaceuticals is an automated drug discovery platform. The company combines experimental biology, automation, and artificial intelligence in a parallel system that aims to efficiently identify treatments for any disease which can be modeled at the cellular level. The company uses computer vision to study images of how diseases affect healthy cells and claims to have put together the largest biological image set in the world, as it tracks almost half a million experiments a week.Â
Recursion Pharmaceuticals has broadened its platform to probe data from automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. While the company tries to make its own drugs for rare discoveries, it has also sought partnerships with major pharmaceutical companies like Sanofi and Takeda, on other rare diseases, hoping to tackle oncology and inflammation.
The company is headquartered in Salt Lake City, Utah and was founded by Blake Borgeson, Chris Gibson, and Dean Li in 2013.Â
Recursion Pharmaceuticals Press Mentions
Stay in the know about the latest news on Recursion Pharmaceuticals
Recursion Raises $239 Million Series D Round, Strikes Deal With Bayer
Wall Streets Journal • Sep 09, 2020
LabGenius raises $10M to use AI for protein drug discovery
TechCrunch • Oct 22, 2019
How To Spot A Synthetic Biology Unicorn
Forbes • Sep 27, 2019
The subtle art of really big data: Recursion Pharma maps the body
zdnet • Jul 25, 2019
Salt Lake's Recursion Pharma nails down $121 million in new funding
deseretnews • Jul 19, 2019
Investors in Recursion Pharmaceuticals
Discover investors in Recursion Pharmaceuticals stock and explore their portfolio companies
Recursion Pharmaceuticals Management
Leadership team at Recursion Pharmaceuticals
Co-Founder and Chief Executive Officer
Chris Gibson
Senior Vice President of Translational Discovery & Chief Evangelist
Ron Alfa
Join now and verify your accreditation status to gain access to:
- Recursion Pharmaceuticals current valuation
- Recursion Pharmaceuticals stock price
- Available deals in Recursion Pharmaceuticals and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Recursion Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Recursion Pharmaceuticals through EquityZen funds. These investments are made available by existing Recursion Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Recursion Pharmaceuticals stock?
Shareholders can sell their Recursion Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
